Skip to main navigation
Skip to search
Skip to main content
UK Health Security Agency Main
Search content at UK Health Security Agency
Main
Profiles
Research units
Projects
Research output
Prizes
Activities
Impacts
Micafungin for the treatment of invasive aspergillosis
David Enoch
*
, S. F. Idris
, S. H. Aliyu
, C. Micallef
, O. Sule
, J. A. Karas
*
Corresponding author for this work
Cambridge Lab Addenbrookes
Research output
:
Contribution to journal
›
Review article
›
peer-review
35
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Micafungin for the treatment of invasive aspergillosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Invasive Aspergillosis
100%
Micafungin
100%
Neutropenia
22%
Antifungal Agents
22%
Invasive Candidiasis
11%
Candida
11%
Randomized Controlled Trial
11%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
11%
Clinical Application
11%
Febrile Patients
11%
Bone Marrow Cells
11%
Immunocompromised Patients
11%
Japan
11%
Randomized Clinical Trial
11%
Clinical Evidence
11%
Aspergillosis
11%
Aspergillus Spp
11%
Esophageal Candidiasis
11%
Stem Cell Transplantation
11%
Antifungal Therapy
11%
Antifungal Drugs
11%
Candida Infection
11%
Aspergillus Infection
11%
Chemotherapy-induced Neutropenia
11%
Echinocandin Antifungal
11%
Pharmacology, Toxicology and Pharmaceutical Science
Invasive Aspergillosis
100%
Micafungin
100%
Antifungal Agent
33%
Neutropenia
33%
Aspergillosis
22%
Candida
11%
Invasive Candidiasis
11%
Immunocompromised Patient
11%
Chemotherapy
11%
Randomized Controlled Trial
11%
Clinical Study
11%
Base
11%
Candidiasis
11%
Aspergillus
11%
Esophagus Candidiasis
11%
Antifungal Therapy
11%
Echinocandin
11%